HOME >> MEDICINE >> NEWS
Moderate to severe sleep apnea significantly raises stroke risk, study finds

SAN DIEGO-Moderate to severe cases of the nighttime breathing problem known as obstructive sleep apnea significantly increases the risk of suffering a stroke, according to a study to be presented at the American Thoracic Society International Conference on May 23.

The study of 1,475 people found that those with moderate to severe sleep apnea at the beginning of the study were 3 to 4 times more likely to have a stroke than a comparable group of patients without sleep apnea during the next four years.

The study did not find any significant increase in the odds of having a stroke for people with mild sleep apnea compared with people without sleep apnea.

"The stroke risk we found for people with moderate to severe sleep apnea is quite significant-double the risk of other well-known risk factors for stroke, such as hypertension or diabetes," said senior researcher Douglas Bradley, M.D., Professor of Medicine and Director of the Centre for Sleep Medicine and Circadian Biology at the University of Toronto. He and colleagues Michael Arzt, M.D., and Terry Young, Ph.D., found that the risk of stroke was significant even after other risk factors for stroke, such as high blood pressure and obesity, were taken into account.

In obstructive sleep apnea, a person's airways narrows, or totally collapses, during sleep. As a result, a person stops breathing briefly multiple times throughout the night. The person's sleep is interrupted often, which may cause excessive daytime sleepiness or even high blood pressure.

The patients in the study were defined as having moderate to severe obstructive sleep apnea if their breathing stopped or slowed at least 20 times per hour of sleep. People whose breathing stopped or slowed between 5 and 20 times per hour of sleep were considered to have mild sleep apnea.

One reason obstructive sleep apnea may increase stroke risk is that it has been shown to cause high blood pressure, which is the most comm
'"/>

Contact: Jim Augustine
619-525-6216
American Thoracic Society
23-May-2005


Page: 1 2

Related medicine news :

1. Moderate drinking lowers womens risk of heart attack
2. Moderate alcohol intake associated with better mental function in older women
3. Moderate stress during pregnancy does not harm child development
4. Moderate drinking associated with better cognition in women
5. Moderately heavy models may actually lower womens self-esteem
6. Moderate to severe sleep-disordered breathing can lead to stroke
7. Moderate alcohol consumption can act as a blood thinner
8. Moderate exercise yields cardiovascular benefits
9. Moderate alcohol use linked to increase in breast cancer risk
10. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
11. Global warmings threat to New York region and how to avoid severe consequences

Post Your Comments:
(Date:10/20/2014)... 2014 Allegheny General Hospital’s (AGH) Cardiovascular ... physicians to repair a damaged mitral valve as the ... system, developed by Abbott Vascular , is designed ... life-threatening condition in which the heart’s mitral valve leaflets ... from the heart’s left ventricle into the left atrium. ...
(Date:10/20/2014)... IN (PRWEB) October 20, 2014 ... Start, a secure cloud solution that enables healthcare ... of the ultimate healthcare-specific customer relationship management (“CRM”) ... meet the unique needs of the healthcare industry, ... experience for providers and patients by combining healthcare ...
(Date:10/20/2014)... 2014 AttorneyOne.com, a recognized authority on law, ... the FDA on Sit and Slim II . ... purchase or use Sit and Slim II because it contains ... promoted as weight loss product on various websites and possibly ... in 2010 for safety reasons, can significantly increase blood pressure ...
(Date:10/20/2014)... National Teen Driver Safety Week is October 19-25, 2014 and ... AAP, http://www.ohioaap.org ) is joining the National Highway Traffic ... talk to their teens and always set the rules before ... leading cause of death for U.S. teens. In 2012, there ... (42%) of those teen drivers were killed in crashes. While ...
(Date:10/20/2014)... 20, 2014 Houston plastic surgeon ... key elements of his innovative True Form Tummy ... surgery residents and faculty at The University of ... too, was once a medical student. Patronella, who is ... cosmetic plastic surgery practices in Texas, The Aesthetic ...
Breaking Medicine News(10 mins):Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:FDA Advises Not to Use Sit and Slim II: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Plastic Surgeon Patronella Presents Artistically-Inspired Tummy Tuck Method to Future Generation of Plastic Surgeons in Texas 2
(Date:10/17/2014)... , October 17, 2014 Investor-Edge ... Inc. (NASDAQ: ARNA ), NPS Pharmaceuticals Inc. ... XOMA ), Momenta Pharmaceuticals Inc. (NASDAQ: ... Free research on these five companies can be accessed ... on Thursday, October 16, 2014, ended on a mixed ...
(Date:10/17/2014)... 17, 2014  UBM Medica US announces that ... and other clinicians who treat patients with type ... effective use of insulin .  Nearly ... replacement therapy – daily injections of one or ... in the function of pancreatic beta cells. Insulin is ...
(Date:10/17/2014)... -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" ... biopharmaceutical company in China , ... from the China Food and Drug Administration (the ... concentrate ("PCC") at its Shandong Taibang facility. The ... facility for Good Manufacturing Practices ("GMP") compliance in ...
Breaking Medicine Technology:Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 2Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 3Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 4Biotech Equities Technical Briefing - Arena Pharma, NPS Pharma, XOMA, Momenta Pharma, and Catalyst Pharma Partners 5Endocrinology Network Features Special Coverage on Effective Use of Insulin 2Endocrinology Network Features Special Coverage on Effective Use of Insulin 3China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 2China Biologic Receives Approval for Commercial Manufacturing of Human Prothrombin Complex Concentrate at Shandong Taibang Facility 3
Cached News: